Frontlight ResearchEarly access
Trial site
Herz-und Diabeteszentrum NRW Universitaetsklinik der Ruhr-Universitaet Bochum
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation1 trial
- Heart failure1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 32 trials
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Applied Therapeutics, Inc.1 trial
- Janssen Research & Development, LLC1 trial
Running trials
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
Site data: ClinicalTrials.govUpdated 19 Nov 2026